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Background: microRNAs (miRNAs) in fish have not been as extensively studied as those in mammals. The fish species
Takifugu rubripes is an intensively studied model organism whose genome has been sequenced. The T. rubripes genome
is approximately eight times smaller than the human genome, but has a similar repertoire of protein-coding
genes. Therefore, it is useful for identifying non-coding genes, including miRNA genes. To identify miRNA expression
patterns in different organs of T. rubripes and give fundamental information to aid understanding of miRNA populations
in this species, we extracted small RNAs from tissues and performed deep sequencing analysis to profile T.
rubripes miRNAs. These data will be of assistance in functional studies of miRNAs in T. rubripes.
Results: After analyzing a total of 139 million reads, we found miRNA species in nine tissues (fast and slow muscles,
heart, eye, brain, intestine, liver, ovaries, and testes). We identified 1420 known miRNAs, many of which were strongly
expressed in certain tissues with expression patterns similar to those described for other animals in previous reports.
Most miRNAs were expressed in tissues other than the ovaries or testes. However, some miRNA families were highly
abundant in the gonads, but expressed only at low levels in somatic tissue, suggesting specific function in germ cells.
The most abundant isomiRs (miRNA variants) of many miRNAs had identical sequences in the 5′ region. However,
isomiRs of some miRNAs, including fru-miR-462-5p, varied in the 5′ region in some tissues, suggesting that they
may target different mRNA transcripts. Longer small RNAs (26–31 nt), which were abundant in the gonads, may
be putative piRNAs because of their length and their origin from repetitive elements. Additionally, our data include
possible novel classes of small RNAs.
Conclusions: We elucidated miRNA expression patterns in various organs of T. rubripes. Most miRNA sequences are
conserved in vertebrates, indicating that the basic functions of vertebrate miRNAs share a common evolution. Some
miRNA species exhibit different distributions of isomiRs between tissues, suggesting that they have a broad range of
functions.
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MicroRNAs (miRNAs) are a dominant class of short
transcripts that regulate gene expression in both animals
and plants [1]. Most miRNA genes are transcribed by
RNA polymerase II, producing a long hairpin structure
called a primary miRNA (pri-miRNA) [2]. The pri-
miRNA is subsequently processed to a precursor miRNA
(pre-miRNA) by a microprocessor called Drosha [3–5].
Exportin-5 then mediates the transport of the pre-* Correspondence: asakawa@mail.ecc.u-tokyo.ac.jp
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unless otherwise stated.miRNA to the cytoplasm where it is further processed to
a ~22 nt miRNA duplex by Dicer [6]. Usually, one strand
of the duplex is loaded onto an AGO protein [7, 8] and this
complex then binds to the 3′-untranslated region of
mRNAs and functions in transcript degradation or
translational repression [1, 9]. In recent years, many
studies of miRNAs in animals have been published. In
miRBase 19.0, there are 2042 human, 1281 mouse
(Mus musculus), 791 chicken (Gallus gallus), and 247
zebrafish (Danio rerio) mature miRNAs recorded [10].
Although the functions of most miRNAs have not yet
been fully elucidated, the majority of miRNA se-
quences are evolutionarily conserved among species,n Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tion [11]. Studies of model organisms, such as small
fish, provide convenient ways to understand how miR-
NAs function, which is often difficult in humans [12].
The zebrafish, whose draft genome was reported re-
cently, is the most popular species in which to analyze fish
miRNAs [12]. Most studies of miRNAs in zebrafish have
explored their roles in tissue development and differenti-
ation [13, 14]; there has been less focus on expression in
specific tissues. Therefore, tissue-specific miRNAs remain
to be identified in fish. In addition, although there are 344
miRNA genes encoded in the zebrafish genome, as re-
ported in miRBase 19.0 [10], this number is far lower than
that in humans (1600) and mice (855), suggesting that
miRNAs in fish have not been fully catalogued. The inves-
tigation of miRNAs in T. rubripes, in addition to that in
zebrafish, would be a significant contribution to our
knowledge of fish miRNAs and would provide essential in-
formation concerning the biological function of many
conserved miRNAs in vertebrates. However, even though
most miRNA sequences are conserved in vertebrates,
some miRNAs with low expression levels seem to be non-
conserved or organism specific. The identification and
characterization of fish-specific miRNAs would contribute
to our understanding of how fish are different from other
vertebrates.
In this study, we performed next-generation sequencing
of small RNAs in T. rubripes to identify miRNA expres-
sion patterns in different organs of T. rubripes and give
fundamental information to aid understanding of miRNA
populations in this species. These data will be of assistance
in functional studies of miRNAs in T. rubripes.
Results
Sequencing of T. rubripes small RNAs
We obtained a total of 138,786,706 reads of 35 nucleotides,
with additional exact barcode sequences. Low-quality reads
were eliminated using our own Perl scripts. After the trim-
ming of 3′ adaptors, 50,653,035 small RNA reads of 1–35
nucleotides were retrieved (Additional files 1 and 2).
Size distribution of small RNAs
We constructed a small RNA size distribution profile for
each tissue. In somatic tissue, small RNAs of 22 nucleo-
tides were the most abundant, followed by those of 21
and 23 nucleotides. In the ovaries and testes, the vast
majority of small RNAs were 26–28 nucleotides in
length, with most having 27 nucleotides (Fig. 1).
Proportion of miRNAs in individual tissues
Because miRNA sequences are conserved in vertebrates,
we identified miRNAs by conducting a homology search
against the miRNA database. After investigating the length
distributions of known miRNAs deposited in miRBase 19.0[10], we found that almost every miRNA was 18–25 nt in
length. Therefore, small RNA sequences (18–25 nucle-
otides in length) were subjected to a BLAST search
against mature miRNAs deposited in miRBase 19.0
[10]. The criteria for miRNA annotation were as fol-
lows (Additional file 1): 1. Query reads exactly match
the reference sequences; 2. Reads with 1–2 nt extended
or shortened at the 5′ end, and/or reads with 1–4 nt
extended or shortened at the 3′ end of known miRNAs.
Using these criteria, among the small RNA sequence
reads approximately 32.1 % in fast muscle, 34.5 % in
slow muscle, 32.2 % in heart, 30.3 % in eye, 32.2 % in
brain, 34.2 % in intestine, and 33.5 % in liver were iden-
tified as miRNAs. However, the proportion of small
RNA sequence reads that were miRNAs in the ovaries
and testes was only 10.8 and 2.5 %, respectively (Fig. 2,
Additional file 3).
Because of these stringent criteria, large numbers small
RNAs were not identified, because of possible 3′ variations
or sequence errors. We then employed more flexible cri-
teria (Additional file 1). Specifically, if sequences of the
first 10 nucleotides were identical to those of known miR-
NAs, we performed further analysis. Among these se-
quences, we first investigated those that completely
matched a continuous miRNA sequence of 16 nt or more.
Following these criteria, among the small RNA sequence
reads, approximately 40.4 % in fast muscle, 43.7 % in slow
muscle, 45.7 % in heart, 33.8 % in eye, 45 % in brain,
43.2 % in intestine, 38.6 % in liver, 11 % in ovaries, and
1.6 % in testes were identified as miRNAs. If the continu-
ous sequences of perfect match were less than 16 nt, we
used a Smith-Waterman algorithm in FASTA v36 to
evaluate the reads. We set the parameters as ‘5’ for match
and ‘−4’ for mismatch. According to this algorithm, we
considered the sequences with Smith-Waterman scores of
at least 70 as miRNAs. According to these criteria, among
the small RNA sequences, 7.8 % in fast muscle, 6.5 % in
slow muscle, 7.2 % in heart, 5.1 % in eye, 8.2 % in brain,
8.3 % in intestine, 5.9 % in liver, 1.7 % in ovaries, and 0.4 %
in testes, were retrieved as miRNAs. Among the reads
in which the first 10 nucleotides were identical with
those of known miRNAs, the remaining sequences were
annotated as putative miRNAs, which represented
0.4 % in fast muscle, 0.4 % in slow muscle, 0.5 % in
heart, 0.9 % in eye, 0.5 % in brain, 0.4 % in intestine,
0.4 % in liver, 1.5 % in ovaries, and 1.2 % in testes
(Fig. 2, Additional files 4 and 5).
The vast majority of miRNAs in all tissues was approxi-
mately 21–23 nt in length. In the eye, brain, and intestine,
the numbers of miRNAs that were 21 nt in length
were similar to the numbers that were 22 nt in length
(Additional file 6). For putative miRNAs, sequences that
were 22 nt were the most abundant in skeletal muscle,






Fig. 1 Size distribution pattern of small RNAs in different tissues of T. rubripes. Size distribution pattern of small RNA reads after normalizing against 1
million 1–35 nt small RNA reads; fast muscle (a), slow muscle (b), heart (c), eye (d), brain (e), intestine (f), liver (g), ovaries (h), and testes (i)




Fig. 2 miRNA proportions as percentages of 18–25 nt small RNAs. The dark blue color indicates reads that exactly matched the reference
sequences, 1–2 nt extended or shortened at the 5′ end, or 1–4 nt extended or shortened at the 3′ end of known miRNAs. The red color indicates
the complete match of continuous sequences of 16 nt or more. The green color indicates the matching of continuous sequences of less than
16 nt with a Smith-Waterman score equal to or more than 70. The purple color indicates the matching of continuous sequences of less than
16 nt with a Smith-Waterman score less than 70. The light blue color indicates 18–25 nt unidentified small RNAs. Fast muscle (a), slow muscle (b),
heart (c), eye (d), brain (e), intestine (f), liver (g), ovaries (h), and testes (i)
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putative miRNAs that were 20 nt in length were the most
highly expressed (Additional file 6).We also investigated the proportion of miRNAs in
small RNAs of 18–25 nt in each tissue. Approximately






Fig. 3 (See legend on next page.)
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Fig. 3 Comparison of next-generation sequencing and qPCR-based profiling of representative ubiquitous and tissue-specific miRNAs. Expression
profiles of ubiquitous (a), muscle-specific (b), skeletal muscle-specific (c), heart and slow muscle-specific (d), eye-specific (e), brain and eye-specific
(f), intestine-specific and liver-specific (g), liver-specific (h), ovary-specific (i), and testes-abundant (j) miRNAs. The left-hand y axis shows the result
from q-PCR and right-hand y axis shows the result from next-generation sequencing
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eye, 18–25 in brain, 19–24 in intestine, and 19–23 in
liver were categorized as miRNAs, including putative
miRNAs. In the gonads, for each length of small RNA
between 18 and 25 nt, less than 50 % were identified as
miRNAs, including putative miRNAs, except for small
RNAs of 22 nt in the ovaries (Additional file 7).
We constructed a pie chart of the proportion of miR-
NAs in small RNA populations of 1–35 nt. More than
50 % of small RNAs in skeletal muscle, heart, brain, and
intestine were identified as miRNAs, and in the eye and
liver, 36.6 and 49.1 %, respectively, were categorized as
miRNAs. In the ovaries and testes, only 5.8 and 1 %, re-
spectively, of the small RNAs were annotated as miR-
NAs. In addition, the major proportion of small RNAs
in the gonads was 26–31 nt (Additional file 8).
Expression profile of T. rubripes miRNAs in different
tissues
For each tissue, we counted the number of each miRNA
and generated a miRNA expression profile across the tis-
sues. The number of reads of individual miRNAs was nor-
malized against the total number of 18–25 nt small RNA
reads in each tissue, giving the number of reads for an in-
dividual as miRNAs per million (Additional file 9). The ex-
pression profile showed that many miRNAs were highly
expressed in more than one tissue, or were ubiquitously
expressed, such as fru-miR-145-5p, which exhibited a high
expression level in all tissues. However, some miRNAs ex-
hibited a biased expression in specific tissues. For example,
fru-miR-1-3p was muscle specific, fru-miR-196a-5p was
skeletal muscle specific, fru-miR-499-5p was heart and
slow muscle specific, fru-miR-204-5p was eye specific, fru-
miR-9-3p was brain and eye specific, fru-miR-192-5p was
intestine and liver specific, fru-miR-122-5p was liver spe-
cific, and fru-miR-202-5p was ovary specific. Even though
the ovaries and testes had a much lower proportion of
miRNAs than somatic tissue, some miRNAs, such as fru-
miR-202-5p and fru-miR-2478-3p, had higher levels of
expression in the ovaries and testes, respectively, than
in somatic cells. These results were confirmed by stem-
loop reverse-transcription polymerase chain reaction
(RT-PCR) (Fig. 3).
Quantitative PCR of representative ubiquitous and tissue-
specific miRNAs in T. rubripes
Ten miRNAs, identified above, were selected for stem-loop
quantitative PCR analysis to confirm the sequencing results(Fig. 3). The next-generation sequencing results of fru-
miR-145-5p, fru-miR-1-3p, fru-miR-204-5p, fru-miR-9-3p
and fru-miR-122-5p correlated well with those of
q-PCR. However, for fru-miR-499-5p, fru-miR-192-5p,
fru-miR-196a-5p, fru-miR-202-5p (data not shown)
and fru-miR-2478-3p, the results from q-PCR were
not consistent with the sequencing results. These in-
consistencies may be caused by the primers that were
not specific enough to the target miRNAs.Putative differentially expressed miRNAs in muscle tissue
To identify miRNAs that exhibited specific expression
in fast, slow, or cardiac muscles, the relative ratios of
normalized reads were used to identify differentially
expressed miRNAs among the muscle tissues. First, we
compared the miRNA expression profile between fast
and cardiac muscle. Fru-miR-206-3p, fru-miR-10b-5p,
fru-miR-10d-5p, fru-miR-133b-3p, and fru-miR-133-3p
exhibited 434, 77, 60, 17, and 15 times higher levels of
expression, respectively, in fast muscle compared with
cardiac muscle, while fru-miR-144-5p, fru-miR-499-5p,
fru-miR-187-3p, fru-miR-499a-5p, and fru-miR-140-3p
exhibited 51-, 41-, 37-, 33-, and 17-fold higher expres-
sion levels, respectively, in heart muscle compared with
fast muscle. Second, we compared miRNA expression
profiles between slow and cardiac muscle. Expression
levels of fru-miR-196a-5p, fru-miR-206-3p, fru-miR-194-5p,
fru-miR-192-5p, and fru-miR-10b-5p in slow muscle were
1305-, 529-, 93-, 85-, and 77-fold higher, respectively,
compared with cardiac muscle, while expression levels
of fru-miR-187-3p, fru-miR-30e-3p, fru-miR-140-3p,
fru-miR-218a-5p, and fru-miR-140-5p were 16-, 16-,
10-, 8-, and 6-fold higher, respectively, in cardiac
muscle compared with slow muscle. We also compared
miRNA expression levels between the skeletal muscles.
Fru-miR-30e-3p exhibited an approximately 4-fold higher
expression level in fast muscle compared with slow muscle.
Fru-miR-133a-3p, fru-miR-133a-5p, and fru-miR-3571-5p
exhibited an approximately 3-fold higher level of ex-
pression, in fast muscle compared with slow muscle. In
contrast, fru-miR-126b-5p, fru-miR-194-5p, fru-miR-
499-5p, fru-miR-30e-5p, and fru-miR-30c-5p exhibited
121-, 21-, 13-, 11-, and 4-fold higher levels of expres-
sion, respectively, in slow muscle compared with fast
muscle (Table 1). However, these differential results are
putative because they are base on one transcriptome
analysis.
Table 1 Top five putative differentially expressed miRNAs compared between 2 muscle tissues
Fast muscle > cardiac muscle
miRNA Fast muscle (RPM) Fast muscle/heart Heart (RPM)
fru-miR-206-3p 94,778 434 218
fru-miR-10b-5p 2310 77 30
fru-miR-10d-5p 1516 60 25
fru-miR-133b-3p 16,735 17 1003
fru-miR-133-3p 58,952 15 3951
Cardiac muscle > fast muscle
miRNA Heart (RPM) Heart/fast muscle Fast muscle (RPM)
fru-miR-144-5p 1012 51 20
fru-miR-499-5p 28,506 41 699
fru-miR-187-3p 1483 37 40
fru-miR-499a-5p 1179 33 36
fru-miR-140-3p 10,721 17 613
Slow muscle > cardiac muscle
miRNA Slow muscle (RPM) Slow muscle/heart Heart (RPM)
fru-miR-196a-5p 1035 1305 1
fru-miR-206-3p 115,467 529 218
fru-miR-194-5p 1065 93 12
fru-miR-192-5p 11 732 85 138
fru-miR-10b-5p 2329 77 30
Cardiac muscle > slow muscle
miRNA Heart (RPM) Heart/slow muscle Slow muscle (RPM)
fru-miR-187-3p 1483 16 92
fru-miR-30e-3p 4473 16 280
fru-miR-140-3p 10,721 10 1108
fru-miR-218a-5p 1380 8 168
fru-miR-140-5p 4288 6 673
Fast muscle > slow muscle
miRNA Fast muscle (RPM) Fast muscle/slow muscle Slow muscle (RPM)
fru-miR-30e-3p 1239 4 280
fru-miR-133a-3p 48,921 3 14,148
fru-miR-133a-5p 14,675 3 5286
fru-miR-3571-5p 3257 3 1176
fru-miR-133-5p 2581 2 1089
Slow muscle > fast muscle
miRNA Slow muscle (RPM) Slow muscle/fast muscle Fast muscle (RPM)
fru-miR-126b-5p 1350 121 11
fru-miR-194-5p 1065 21 50
fru-miR-499-5p 9193 13 699
fru-miR-30e-5p 6361 11 591
fru-miR-30c-5p 6669 4 1601
miRNAs with more than a 1.5-fold difference in expression between muscle tissues and expression levels of more than 1000 RPM were selected
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We used the relative ratios of normalized reads to find dif-
ferentially expressed miRNAs in the ovaries and testes, to
identify sex-specific or sexually dimorphic miRNAs. Of the
miRNAs that exhibited higher expression levels in the
ovaries compared with the testes, fru-miR-214-3p and
fru-miR-143-3p exhibited the greatest differences in ex-
pression. They exhibited an approximately 24-fold
higher expression level, in the ovaries compared with
the testes, followed by fru-miR-202-5p, fru-miR-24-3p,
and fru-miR-145b-5p, whose expression levels were ap-
proximately 22-, 20-, and 20-fold higher, respectively,
in the ovaries compared with the testes. Of the miR-
NAs that exhibited greater expression in the testes
compared with the ovaries, fru-miR-2478-3p and fru-
miR-2898-3p exhibited levels in the testes that were
twice those in the ovaries (Table 2). However, we could
only claim these results as putative differential expres-
sion patterns as described above.
IsomiRs in T. rubripes
IsomiRs refer to mature miRNA sequences in which a few
nucleotides vary at the 5′/3′ termini compared with the
major mature miRNAs that originated from the same
miRNA hairpin. We chose fru-miR-145-5p, which was ubi-
quitously expressed, as a representative example to demon-
strate the variation in mature miRNA sequences. The
sequence of fru-miR-145-5p was identical in every tissue.
However, the sequence was different at the 3′ terminus
compared with the miR-145-5p entries deposited in miR-
Base 19.0 [10]. Fru-miR-145-5p exhibited more nucleotide
variation in the 3′ region than in the 5′ region. Among iso-
miRs, approximately 47.7 % in fast muscle, 48.2 % in slow
muscle, 56.7 % in heart, 58.1 % in eye, 49.2 % in brain,
48.2 % in intestine, 45.1 % in liver, 53.8 % in ovaries, and
44.3 % in testes exhibited 3′ variation compared with the
most abundant fru-miR-145-5p. Approximately 0.4 % inTable 2 Putative differentially expressed miRNAs compared
between ovaries and testes
Ovaries > testes
miRNA Ovaries (RPM) Ovaries/testes Testes (RPM)
fru-miR-214-3p 3055 24 125
fru-miR-143-3p 6965 24 293
fru-miR-202-5p 9054 22 409
fru-miR-24-3p 4170 20 208
fru-miR-145b-5p 5933 20 302
Testes > ovaries
miRNA Testes (RPM) Testes/ovaries Ovaries (RPM)
fru-miR-2478-3p 2691 2 1133
fru-miR-2898-3p 1503 2 753
miRNAs with more than a 1.5-fold difference in expression between ovaries
and testes and expression levels of more than 1000 RPM were selectedfast muscle, 0.4 % in slow muscle, 0.5 % in heart, 0.4 % in
eye, 0.4 % in brain, 0.4 % in intestine, 0.6 % in liver, 0.8 % in
ovaries, and 1.3 % in testes exhibited variation at both the
3′ and 5′ ends. Less than 0.5 % of isomiRs exhibited only
5′ variation in fast muscle, slow muscle, heart, eye, brain,
intestine, liver, ovaries, and testes. A sliding of the Drosha
cleavage site at the 5′ terminus occurred in a small popula-
tion of fru-pri-miR-145 (Additional file 10). This led to the
production of different seed sequences in mature fru-miR-
145 isomiRs, and they may recognize different target
mRNAs. We investigated the major sequence of each
miRNA species across the tissues; fru-miR-462-5p, fru-
miR-101b-3p, and fru-miR-133-3p exhibited significant
variation at the 5′ terminus in some tissues (Table 3,
Additional files 11, 12 and 13).
Distribution of different small RNA categories in each
tissue
To classify the remaining unidentified small RNAs
(18–25 nt unidentified small RNAs and 26–35 nt
small RNAs), we performed homology searches against
the NCBI database (Fig. 4). In the 1–35 nt population,
the majority of small RNAs in the ovaries and testes
were derived from repetitive elements. Additionally,
70–75 % of them were identified to be 26–31 nt. The
major proportion of small RNAs of each length in the
ovaries and testes (except for 21–22 nt in the ovaries) were
also derived from repetitive elements (Additional file 7). Fi-
nally, in each somatic tissue, only about 1 % of small RNAs
were unidentified; while in the ovaries and testes 11.8 and
15.6 % were unidentified, respectively.
Discussion
Most miRNAs are conserved among species; therefore, we
identified miRNAs by conducting a homology search
against mature miRNAs deposited in miRBase 19.0 [10]. In
the 18–25 nt population, 69–86 % of small RNAs in som-
atic tissue were annotated as miRNAs, whereas only 24 and
5 % of small RNAs in the ovaries and the testes, respect-
ively, were categorized as miRNAs. Although only a small
number of small RNAs in the gonads were identified as
miRNAs, the number of miRNA species in the ovaries and
testes was 591 and 548, respectively, which is similar to the
number of miRNAs in somatic tissue. Among miRNA spe-
cies, we identified 629 in fast muscle, 608 in slow muscle,
488 in heart, 539 in eye, 531 in brain, 519 in intestine, and
538 in liver. Our results suggest that many types of miRNA
might be expressed in the gonads at a low level of expres-
sion. We also identified small RNA sequences as putative
miRNAs that have many variations at the 3′ terminus com-
pared with known miRNAs. These results show that, in
every tissue, not more than 1 % of small RNAs was anno-
tated as putative miRNAs. However, numbers of putative
miRNA species were higher than those of miRNAs in every
Table 3 miRNAs in which major isomiRs exhibited 5′ variation among tissues and their expression levels
miRNA Major sequence Seed sequence Expression level Tissue
fru-miR-462-5p GTAACGGAACCCATAATGCAGCT TAACGGA 47 Fast muscle
fru-miR-462-5p GTAACGGAACCCATAATGCAGCT TAACGGA 119 Slow muscle
fru-miR-462-5p TAACGGAACCCATAATGCAGCT AACGGAA 253 Heart
fru-miR-462-5p GTAACGGAACCCATAATGCAGCT TAACGGA 30 Eye
fru-miR-462-5p TAACGGAACCCATAATGCAGCT AACGGAA 50 Brain
fru-miR-462-5p GTAACGGAACCCATAATGCAGCT TAACGGA 1803 Intestine
fru-miR-462-5p GTAACGGAACCCATAATGCAGCT TAACGGA 119 Liver
fru-miR-462-5p GTAACGGAACCCATAATGCAGCT TAACGGA 87 Ovaries
fru-miR-462-5p GTAACGGAACCCATAATGCAGCT TAACGGA 19 Testes
fru-miR-101b-3p GTACAGTACTATGATAACTGA TACAGTA 85 Fast muscle
fru-miR-101b-3p GTACAGTACTATGATAACTGA TACAGTA 75 Slow muscle
fru-miR-101b-3p GTACAGTACTATGATAACTGA TACAGTA 131 Heart
fru-miR-101b-3p GTACAGTACTATGATAACTGA TACAGTA 97 Eye
fru-miR-101b-3p TACAGTACTATGATAACTGA ACAGTAC 106 Brain
fru-miR-101b-3p GTACAGTACTATGATAACTGA TACAGTA 72 Intestine
fru-miR-101b-3p GTACAGTACTATGATAACTGA TACAGTA 1774 Liver
fru-miR-101b-3p TACAGTACTATGATAACTGA ACAGTAC 24 Ovaries
fru-miR-101b-3p GTACAGTACTATGATAACTGA TACAGTA 15 Testes
fru-miR-133-3p TTGGTCCCCTTCAACCAGCCGT TGGTCCC 1958 Fast muscle
fru-miR-133-3p TTTGGTCCCCTTCAACCAGCC TTGGTCC 785 Slow muscle
fru-miR-133-3p TTGGTCCCCTTCAACCAGCCGT TGGTCCC 225 Heart
fru-miR-133-3p TTGGTCCCCTTCAACCAGCCGT TGGTCCC 17 Eye
fru-miR-133-3p TTGGTCCCCTTCAACCAGCCGT TGGTCCC 4 Brain
fru-miR-133-3p TTGGTCCCCTTCAACCAGCCGT TGGTCCC 4 Intestine
fru-miR-133-3p TTTGGTCCCCTTCAACCAGCCG TTGGTCC 1 Liver
fru-miR-133-3p TTGGTCCCCTTCAACCAGCCGT TGGTCCC 6 Ovaries
Bold indicates isomiRs with variation at the 5′ terminus
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tes were much higher. The number of putative miRNAs
was 1397 in fast muscle, 1242 in slow muscle, 532 in heart,
855 in eye, 508 in brain, 683 in intestine, 910 in liver, 2787
in ovaries, and 2651 in testes, indicating that various species
of putative miRNA might be expressed in each tissue at a
low level of expression. It may also be possible that some
putative miRNAs might be other types of small RNA, frag-
ment contaminants of longer RNAs, or novel miRNAs.
The RNAs of 26–31 nt that originated from repeti-
tive elements were highly expressed in the ovaries and
testes. These small RNAs may be piRNAs, considering
their length and high abundance in gonads. Our re-
sults are similar to those of many previous studies;
piRNAs that are 26–31 nt in size are mainly expressed
in the ovaries and testes [15–20]. piRNAs are associ-
ated with PIWI proteins, which are members of the
Argonaute family [19, 20]. piRNA precursors are tran-
scribed from an intergenic repetitive element or a piRNA
cluster [17, 21–23]. The main function of piRNAs is tomaintain the integrity of the genome by silencing transpos-
able elements [24, 25].
Considering the proportion of miRNAs of each length
from 18 to 25 nt, we found that the brain generated more
variation in miRNA sequence length than did the other tis-
sues (Additional file 7). This is possibly because the brain is
the most complex organ in the vertebrate body. The human
brain comprises 10,000 difference types of neuron [26].
Therefore, a wide range of miRNA variants in the brain
may be involved in brain function. Modifications of miR-
NAs at the 5′ terminus affect the seed region (2–8 nt), and
may lead to differential target recognition [27–30]. Further-
more, 3′ modifications have been reported to be involved
in the stability of miRNAs and the efficiency of target re-
pression [31–33].
After constructing the miRNA expression profiles and
validating the results with stem-loop RT-qPCR, we found
that many miRNAs were ubiquitously expressed. For ex-
ample, fru-miR-145-5p was highly expressed in every tissue.




Fig. 4 Proportions of small RNA components. Fast muscle (a), slow muscle (b), heart (c), eye (d), brain (e), intestine (f), liver (g), ovaries (h), and testes (i)
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entiation and suppressing smooth muscle cell prolifera-
tion [34]. miR-145-5p targets and negatively regulates
the pluripotency factors, OCT4, SOX2, and KLF4, in
human embryonic stem cells [35]. In humans, miR-145-5p
is highly abundant in the gonads and tissues arising from
the mesoderm, such as the heart, spleen, uterus, and
prostate [36]. However, some miRNAs exhibit tissue-
specific expression patterns, suggesting that they play
important roles in those tissues. Our results (highly
expressed miRNAs in some tissues) are in agreement
with previous studies. For example, fru-miR-1 was
abundant in skeletal muscle and the heart, as it is in
many animals. Previous studies have reported that in
skeletal muscle, miR-1 is modulated by serum response
factors (SRFs), such as MyoD and Mef2, which are
muscle differentiation regulators [37]. miR-1 plays a
role in repressing embryonic stem cell differentiation
into non-muscle cells in mice and humans [38]. In the
heart, miR-1 targets the transcription factor Hand2,
which accelerates the expansion of the cardiac muscle
[37]. In mice, over-expression of miR-1 inhibits muscle
proliferation [39]. miR-1 also regulates the develop-
ment of cardiac hypertrophy [40]. In addition, arrhyth-
mogenesis in infarcted rat hearts can be treated by
injection with an antisense strand of miR-1 [41].
Fru-miR-192-5p was the most abundant miRNA in
the intestine. miR-192-5p belongs to the miR-192/215
family [10]. miR-192 and miR-215 share identical seed
sequences, and only differ by two nucleotides [10].
They are tumor suppressor miRNAs, modulated by
p53 (also a tumor suppressor gene), and they play a
role in cell-cycle arrest to prevent tumorigenesis [42–44].
They are biomarkers that are down-regulated in colon
cancer [42, 43]; however, both are up-regulated in gas-
tric cancer, where they target the adhesion molecule
ALCAM [45].
In this study, fru-miR-122 was a liver-specific miRNA.
This result is similar to those from previous studies in other
organisms, such as Drosophila, C. elegans, humans, and
mice. The levels of miR-122 in blood plasma correlate with
aminotransferase levels, which is an indicator of drug-
induced liver injury [46]. Moreover, changes in miRNA
levels can be detected earlier than changes in amino-
transferase levels [46]. Therefore, miR-122 is a potential
diagnostic and prognostic marker for liver pathology
[46]. miR-122 is a tumor suppressor miRNA that nega-
tively regulates ADAM17, resulting in the repression of
hepatocellular carcinoma angiogenesis and metastasis
[47]. Down-regulation of miR-122 can be used as a bio-
marker for hepatic cancer [48].
Some miRNAs exhibit special expression patterns.
For example, fru-miR-202-5p exhibited much higher
expression levels in the ovaries than in the somatictissue, although the proportion of miRNAs in somatic
tissue is much greater than that in the gonads, suggesting
that they play crucial roles in germ cells. miR-202-5p ex-
hibits sexual dimorphism during gonadal sex differentiation
[49, 50]. In embryonic chickens, it is up-regulated during
testes differentiation from the onset of testes development
[51]. During development of the mouse testes, miR-202-5p
is a direct transcriptional target of SOX9, a transcription
factor that plays a role in male sex determination [50]. It is
highly expressed in Sertoli cells when the male primordial
germ cells differentiate into the testes [50]. However, in our
study, fru-miR-202-5p was detected in both the ovaries and
the testes because our sample was at a mature stage, a re-
sult that is consistent with previous studies; miR-202-5p is
a postnatal gonad-specific miRNA in Atlantic halibut (Hip-
poglossus hippoglossus), Xenopus, mice, pigs, and humans
[52–56]. These results suggest that miR-202-5p has an im-
portant function that involves sex determination during tes-
tes development, and also plays a crucial role in postnatal
ovaries and testes [50].
Most of the miRNA species exhibited variation at
the 3′ terminus, while variation at the 5′ terminus was
not as prevalent as that at the 3′ terminus [29]. Shifts
in the seed region (nucleotide positions 2–8 from the
5′ terminus) lead to differential target recognition and
a role in gene regulation [27–30]. In general, the
major variant of each miRNA species was common to
all the tissues, but for some miRNA species the most
abundant variants had different seed sequences among
the nine tissues, suggesting that miRNAs may have
different targets and functions in different tissues.
In this study, we identified many miRNAs in T.
rubripes. To validate the putative piRNAs, more infor-
mation regarding associated proteins [19, 20] and exam-
ination of nucleotide bias at the specific positions are
required [19, 21, 22]. Our data also showed other classes
of small RNAs that may have important, but yet uniden-
tified, functions.Conclusions
In this study, we investigated miRNA expression pat-
terns in various organs of T. rubripes. We identified
1420 known miRNA species. Many miRNAs exhibited
conserved tissue-specific expression patterns, indicating
that their basic functions share a common evolution among
vertebrates. miRNAs were mainly expressed in tissues other
than the gonads, whereas putative piRNAs were highly
abundant in the ovaries and testes; however, some miRNA
species were highly abundant in the gonads. The most
abundant isomiRs of specific miRNAs may have different
functions in different tissues. Our data may also include
new kinds of small RNAs. Our data may also include new
kinds of small RNAs.
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Preparation and sequencing of small RNA libraries
All procedures in this study were performed according
to the Animal Experimental Guidelines of the Ethical
Committee of The University of Tokyo. Total RNA was
extracted from 0.1 g of each tissue (fast and slow muscle,
heart, eye, brain, intestine, liver, ovaries, and testes dis-
sected from two individual adult T. rubripes) that had
been stored in RNAlater solution for 1 h (Applied Bio-
systems, Foster City, CA, USA). Total RNA was ex-
tracted using a mirVana miRNA Isolation Kit (Applied
Biosystems). To purify small RNA, total RNA was frac-
tionated through a flashPAGE Fractionator (Applied Bio-
systems), and small RNA was retrieved. Nine small RNA
libraries were constructed, using Small RNA Library
Preparation for SOLiD Sequencing (Applied Biosystems).
The entire libraries were sequenced using the SOLiD 3
next-generation sequencer (Applied Biosystems).
Small RNA data annotation
After the acquisition of small RNA data from the sequen-
cer, low-quality reads and 3′ sequencing adapters were
eliminated and trimmed, respectively, by our own Perl
script. However, some adapter sequences were shorter than
4 nt, and we could not judge whether they were the real
adaptor sequences or belonged to the 3′ part of small RNA
sequences. We decided not to remove the short sequences;
therefore, many small RNAs were 35 nt in length. In
addition, the population of 32–34 nt sequences was absent
after removal of the adaptor. Small RNAs (18–25 nt) were
BLAST-searched against mature miRNAs deposited in
miRBase 19.0 (www.mirbase.org/), using CLC genomics
workbench software (CLC bio, Aarhus, Denmark). The se-
quences with non-base pair changes, 1–2 nt extended or
shortened at the 5′ end, or 1–4 nt extended or shortened
at the 3′ end were annotated as miRNAs. Owing to 3′ vari-
ations or sequence errors, many small RNAs could not be
annotated. Therefore, we separated reads that had identical
nucleotides in positions 1–10 with known miRNAs and
performed downstream analysis. Sequences that had an
alignment length that was equal to or more than 16 nt with
known miRNAs were regarded as miRNAs. In cases where
small RNAs had an alignment length of less than 16 nt, we
used the Smith-Waterman score in FASTA v36 (http://
faculty.virginia.edu/wrpearson/fasta/fasta36/) to evaluate
the alignment. The parameter was set to add ‘5’ and ‘−4’
scores for match and mismatch cases, respectively. We
identified sequences with a score equal to or more than 70
as miRNAs. We identified sequences that had a Smith-
Waterman score of less than 70 as putative miRNAs.
miRNA expression profile
The expression levels of individual miRNAs were calculated
as RPM (read per million) and compared among thetissues. The individual miRNA expression level (RPM) was
calculated as: (the number of reads of the individual
miRNA/total number of 18–25 nt small RNA reads in the
tissue) × 106.Data accession numbers
Sequence data sets used in this study were deposited in
the GEO database [57] under the accession number
GSE65404.miRNA Stem loop real time PCR
We choose stem-loop real-time PCR for miRNA quanti-
fication. This method is more specific than linear PCR
as stem-loop primers are designed to be complementary
to the 6 nt of 3′ termini of mature miRNAs [58]. First,
1 μg of total RNA from fast and slow muscles, heart,
eye, brain, intestine, liver (all n = 3), ovaries, and testes
(both n = 2) were used for first-strand cDNA synthesis.
Stem loop primer was added to total RNA (Additional
file 14) and reversed transcribed using Superscript III
(Invitrogen). Subsequently, cDNA was used as a tem-
plate for real-time PCR. The PCR mixture contained
EXPRESS SYBR GreenER qPCR SuperMix Universal
10 μL (Invitrogen), 0.4 μL of 10 μM miRNA-specific for-
ward and universal reverse primer (Additional file 14),
0.4 μL of ROX Reference Dye (25 μM), and was made
up to 20 μL with nuclease free water. Reactions were
performed on an Applied Biosystems 7300 Real-Time
PCR System. Each sample was run in triplicate. miRNA
expression was normalized against that of T. rubripes 5 s
ribosomal RNA (Additional file 14).Additional files
Additional file 1: Figure S1. Small RNA data pipeline analysis. The
diagram represents the data pipeline used to analyze data from
next-generation sequencing and the miRNA annotation criteria.
Additional file 2: Table S1. Number of small RNA reads at each step of
the data pipeline analysis. The number of small RNAs retrieved after
passing small RNA reads through each step of the data pipeline analysis
Additional file 3: Table S2. List of miRNAs and their read numbers in
each tissue of T. rubripes. The order of miRNAs is based on their expression
levels after normalizing reads against 1 million 18–25 nt small RNAs.
Additional file 4: Table S3. List of putative miRNAs and their read
numbers in each tissue of T. rubripes. The order of putative miRNAs is
based on their expression levels after normalizing reads against 1 million
18–25 nt small RNAs.
Additional file 5: Figure S2. Number of miRNA and putative miRNA
species found in each tissue.
Additional file 6: Figure S3. Size distribution patterns of miRNAs and
putative miRNAs in each tissue. The size distribution patterns of 18–25 nt
miRNAs (A) and putative miRNAs (B) reads after normalizing against 1
million 18–25 nt small RNAs, from nine tissues of T. rubripes.
Additional file 7: Figure S4. Ratio of reads of each 18–31 nt RNA
species identified in this study to total small RNA reads in each tissue.
The ratios of miRNAs, putative miRNAs, mRNAs, tRNA/rRNA/snRNAs, other
Wongwarangkana et al. BMC Genomics  (2015) 16:457 Page 13 of 14non-coding RNAs, repeats, reads that failed to align, others and unidentified
small RNAs of 18–31 nt to total small RNA reads.
Additional file 8: Figure S5. miRNA proportions as percentages of
1–35 nt small RNAs. Proportions of 1–17 nt small RNAs, 18–25 nt
miRNAs, 18–25 nt putative miRNAs, 18–25 nt unidentified small RNAs,
26–31 nt small RNAs, and 32–35 nt small RNAs are shown as
percentages of total 1–35 nt small RNAs.
Additional file 9: Table S4. Expression profiles of miRNAs and putative
miRNAs in T. rubripes in all tissues examined. List of known miRNAs and
putative miRNAs, their most abundant sequences, and their read
numbers, after normalization against reads with 1 million 18–25 nt small
RNAs in each tissue.
Additional file 10: Figure S6. Proportions of isomiR variation types as
percentages of total fru-miR-145-5p in each tissue. Proportions of the isomiRs
that exhibited nucleotide variation only in the 3′ region, the isomiRs
that exhibited variation at both the 3′ and 5′ ends, the isomiRs that exhibited
only 5′ variation, and the major sequence of the isomiRs are shown as
percentages of total fru-miR-145-5p.
Additional file 11: Figure S7. IsomiRs of fru-miR-462-5p. The diagrams
represent repertoires of fru-miR-462-5p isomiRs mapped to their miRNA
precursors in each tissue.
Additional file 12: Figure S8. IsomiRs of fru-miR-101b-3p. The diagrams
represent repertoires of fru-miR-101b-3p isomiRs mapped to their
miRNA precursors in each tissue.
Additional file 13: Figure S9. IsomiRs of fru-miR-133-3p. The diagrams
represent repertoires of fru-miR-133-3p isomiRs mapped to their miRNA
precursors in each tissue.
Additional file 14: Table S5. Primers for RT-qPCR. List of stem loop
primers and miRNA gene-specific primers, including internal control forward
primers and a universal reverse primer.
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